Diabetes Mellitus

image.jpg

Derginin Adı: Diabetes Mellitus
Dergi Kayıt Tarihi: 26.4.2015
DergininWebsitesi: http://dia.endojournals.ru/
Dergi Hakkında: The “Diabetes Mellitus” is a peer-reviewed research and clinical journal published quarterly since 1998 under the auspices of Russian Association of Endocrinologists and Federal Endocrinology Research Centre (Moscow). Its content focuses on original papers on clinical, experimental and academic studies, but also includes literature reviews, lectures, case studies and supplementary materials. General discourse of the journal is dedicated to the key aspects of diabetology, encompassing etiology, epidemiology and pathogenesis of diabetes mellitus, novel diagnostic and therapeutic methods, as well as prevention and management of acute and late complications of diabetes mellitus and associated conditions. The intended primary audience of the journal is medical professionals (including diabetologists, endocrinologists, general practitioners, family physicians and pediatricians), scientists and academicians working in the area of endocrinology and diabetology. In 2014 “Diabetes Mellitus” has become fully bilingual, now featuring full-text English versions of all published materials, and adopted the Gold Open Access distribution model. The current editorial board understanding of the journal’s mission is as following: - to facilitate the exchange of clinical experience and scientific data between Russian-speaking and international diabetology communities; - to inform Russian-speaking medical professionals about the relevant and high-quality evidence-based clinical data.
ISSN: 2072-0351
Dergi Dili: English,Russian

Dergi Sayıları

Skip Navigation Links.
Collapse Diabetes MellitusDiabetes Mellitus
Collapse <%$ Resources: Default, Cilt %>: 2002/5<%$ Resources: Default, Cilt %>: 2002/5
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
BIOLOGICHESKAYA ROL' OKSIDA AZOTA PRI SAKHARNOM DIABETE
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
IDENTIFIKATSIYA LOKUSA, ASSOTSIIROVANNOGO S DIABETICHESKOY ...
SAKHARNYY DIABET I ISHEMICHESKAYA BOLEZN' SERDTSA: PROBLEMA...
KLINICHESKAYA GETEROGENNOST' SINDROMA DIABETICHESKOY STOPY
VLIYANIE ANTIGIPERTENZIVNOY TERAPII NA PROGNOZ SERDECHNO-SO...
VLIYANIE MEKSIDOLA I PREDUKTALA NA ELEKTRICHESKUYU NESTABIL...
EFFEKTIVNOST' PRIMENENIYA PREPARATA VESSEL DUE F U BOL'NYKH...
RANNYAYA PERORAL"NAYA SAKHAROSNIZHAYUSHCHAYA TERAPIYA PRI S...
O KOMBINIROVANNOY TERAPII SAKHARNOGO DIABETA TIPA 2
OCENKA EFFEKTIVNOSTI, PERENOSIMOSTI I BEZOPASNOSTI TERAPII ...
EFFEKTIVNOST' LECHENIYA DIABETICHESKOY POLINEYROPATII U DET...
K VOPROSU O PROFILAKTIKE SAKHARNOGO DIABETA TIPA 2
DISTANTSIONNOE MEDITSINSKOE INTERNET-KONSUL'TIROVANIE I OBU...
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
SAKHARNYY DIABET I SERDECHNO-SOSUDISTYE ZABOLEVANIYA: SOSTO...
ROL' GLIKIROVANIYA BELKOV, OKISLITEL'NOGO STRESSA V PATOGEN...
SAKHAROSNIZHAYUSHCHIE SUL'FANILAMIDY I «ISHEMICHESKIY POROG...
MOZHNO LI USPESHNO LECHIT' BOL'NYKH ISHEMICHESKOY BOLEZN'YU...
VOZMOZHNOSTI SOKHRANENIYA NIZHNEY KONECHNOSTI PRI KRITICHES...
PUTI PROFILAKTIKI SAKHARNOGO DIABETA TIPA 2
OSOBENNOSTI KARDIAL'NYKH NARUSHENIY PRI DIABETICHESKOY NEFR...
KONTSENTRATSIYA TSIRKULIRUYUSHCHIKH IMMUNNYKH KOMPLEKSOV I ...
LECHENIE SAKHARNOGO DIABETA TIPA 1 NA SOVREMENNOM ETAPE
EFFEKTIVNOST' AMARILA U BOL'NYKH SAKHARNYM DIABETOM TIPA 2,...
SLUCHAY ZADERZHKI FIZICHESKOGO I POLOVOGO RAZVITIYA V SOCHE...
OBUCHENIE BOL'NYKH SAKHARNYM DIABETOM: PSIKHOLOGICHESKIY AN...
Collapse <%$ Resources: Default, Cilt %>: 2003/6<%$ Resources: Default, Cilt %>: 2003/6
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
EPIDEMIOLOGICHESKIE ISSLEDOVANIYA SAKHARNOGO DIABETA TIPA 1...
METODOLOGICHESKIE ASPEKTY I KLINICHESKAYA ZNACHIMOST' DIABE...
TULOVISHCHNOE OZHIRENIE I INSULINREZISTENTNOST' — KLYUCHEVO...
METABOLICHESKIE OSOBENNOSTI SINDROMA POLIKISTOZNYKH YAICHNI...
SLUCHAY SINDROMA MYUNKHGAUZENA NA FONE VTORICHNOGO SAKHARNO...
INSULINOREZISTENTNOST' PRI SAKHARNOM DIABETE TIPA 1 U PODRO...
LIPIDKORRIGIRUYUSHCHIE EFFEKTY NIZKOY DOZY ATORVASTATINA U ...
KOMBINIROVANNAYA TERAPIYA PREPARATOM GLIBOMET BOL'NYKH SAKH...
PROGRAMMA OBESPECHENIYA ORTOPEDICHESKOY OBUV'YU BOL'NYKH SA...
DIAGNOSTIKA I RASPROSTRANENNOST' INFEKTSIY MOCHEVYVODYASHCH...
PROGRAMMA PODGOTOVKI SPETSIALISTOV V OBLASTI OBUCHENIYA BOL...
LANTUS (INSULIN GLARGIN) — NOVYY INSULIN NA RYNKE ROSSII
OTSENKA KACHESTVA OKAZANIYA MEDITSINSKOY POMOSHCHI BOL'NYM ...
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
ASSOTSIATSIYA POLIMORFIZMA GENA S0D2 I GENA SOD3 S DIABETIC...
GIPERGOMOTSISTEINEMIYA U BOL'NYKH S DIABETICHESKOY NEFROPAT...
UL'TRAZVUKOVAYA DIAGNOSTIKA ZADERZHKI POLOVOGO RAZVITIYA DE...
STRUKTURNO-FUNKTSIONAL'NYE SVOYSTVA ERITROTSITARNYKH MEMBRA...
PRIMENENIE TRIMETAZIDINA U POZHILYKH PATSIENTOV S REFRAKTER...
PRESTARIUM I ARIFON V TERAPII IZOLIROVANNOY SISTOLICHESKOY ...
PSIKHOLOGICHESKIY STATUS BOL'NYKH DIABETICHESKOY RETINOPATI...
DIABETICHESKAYA RETINOPATIYA I ANTIOKSIDANTY
DIABETICHESKAYA RETINOPATIYA — PRICHINA SLEPOTY I INVALIDNO...
AKARBOZA V PROFILAKTIKE SAKHARNOGO DIABETA TIPA 2
Collapse <%$ Resources: Default, Cilt %>: 2007/10<%$ Resources: Default, Cilt %>: 2007/10
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
ASSOTSIATSIYA KHROMOSOMNOY OBLASTI 5Q31.1-Q33.1 (IDDM18) S ...
GENY SINTAZ OKSIDA AZOTA (NOS1, NOS3) V RAZVITII PREDRASPOL...
POVYSHENNAYA EKSKRETSIYA TRANSFORMIRUYUSHCHEGO FAKTORA ROST...
ISSLEDOVANIE INTERVALA QT U DETEY I PODROSTKOV, BOL'NYKH SA...
SISTEMA OSTEOPROTEGERIN (OPG) – LIGAND RETSEPTORA-AKTIVATOR...
PROGNOZIROVANIE RISKA RAZVITIYA MIKROSOSUDISTYKH OSLOZHNENI...
PREIMUSHCHESTVA VKLYUCHENIYA V TERAPIYU BOL'NYKH S METABOLI...
VYYAVLENIE EPIZODOV PREKHODYASHCHEY ISHEMII MIOKARDA U BOL'...
GENERIK ATORVASTATINA TULIP® V LECHENII DISLIPIDEMII U BOL'...
ISPOL'ZOVANIE UL'TRAKOROTKOGO ANALOGA INSULINA LIZPRO U BER...
ANDROGENNYY DEFITSIT U MUZHCHIN S SAKHARNYM DIABETOM 2 TIPA...
GLIBOMET V LECHENII SAKHARNOGO DIABETA 2 TIPA
ANALIZ ZABOLEVAEMOSTI SAKHARNYM DIABETOM 1 TIPA U DETEY KRA...
LIPOIDNYY NEKROBIOZ I DRUGIE PORAZHENIYA KOZHI PRI SAKHARNO...
MESTO BIOLOGICHESKI-AKTIVNYKH DOBAVOK V LECHENII SAKHARNOGO...
NOVOSTI DIABETOLOGII
ZHURNAL «VESTNIK REPRODUKTIVNOGO ZDOROV'YA»
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
POLIMORFIZM GENA CTLA4 (49A/G) V RUSSKOY POPULYATSII U BOL'...
REZISTENTNOST' VOZBUDITELEY RANEVOY INFEKTSII PRI SINDROME ...
EPIDEMIOLOGIYA I PATOGENETICHESKIE FAKTORY SINDROMA DIABETI...
UROVEN' V SYVOROTKE I POCHECHNAYA EKSPRESSIYA MOLEKUL MEZHK...
VLIYANIE SAKHARNOGO DIABETA 2 TIPA NA PROYAVLENIYA GONARTRO...
PRIMENENIE KOMBINATSII METFORMINA I ROSIGLITAZONA PRI SAKHA...
NARUSHENIYA V SISTEME GEMOSTAZA PRI SAKHARNOM DIABETE I PUT...
ZAMESTITEL'NAYA GORMONAL'NAYA TERAPIYA I TECHENIE DISTAL'NO...
SOVREMENNYY ALGORITM LAZERNOY KOAGULYATSII SETCHATKI PRI DI...
EFFEKTIVNOST' I BEZOPASNOST' DVUKHFAZNOGO INSULINA ASPART 3...
KLINIKO-FARMAKOLOGICHESKIE ASPEKTY TITROVANIYA DOZIROVKI ME...
OPYT KLINICHESKOGO PRIMENENIYA PREPARATOV BIOSULIN® R I BIO...
OPYT DISTANTSIONNOGO PREPODAVANIYA ENDOKRINOLOGII S ISPOL'Z...
PRIMENENIE BIOOKISLITEL'NOY TERAPII V LECHENII SAKHARNOGO D...
INNOVATSIONNYE SREDSTVA MESTNOGO LECHENIYA RAN
REZUL'TATY ISSLEDOVANIYA ADVANCE U BOL'NYKH SD 2 TIPA. NOLI...
ISSLEDOVANIE HYVET OSTANOVLENO V SVYAZI S VYYAVLENIEM DOSTO...
NOVOSTI S KONGRESSA ADA 2007
TREBOVANIYA K NAPISANIYU STATEY PO MOLEKULYARNOY GENETIKE
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
14 NOYABRYA 2007 G. – PERVYY VSEMIRNYY DEN' DIABETA, PROVED...
ANALIZ ASSOTSIATSIY POLIMORFIZMA S1159A GENA INTERLEYKINA 1...
RASPROSTRANENNOST' SAKHARNOGO DIABETA 2 TIPA SREDI NAIBOLEE...
SEKRETSIYA INSULINA V NORME I PRI SAKHARNOM DIABETE 2 TIPA
VLIYANIE NARUSHENIYA METABOLIZMA GLYUKOZY NA TECHENIE I ISK...
EFFEKTIVNAYA I GIBKAYA FARMAKOTERAPIYA OZHIRENIYA SEGODNYA ...
EFFEKTIVNOST' KOLLAGENSODERZHASHCHIKH POVYAZOK V KOMPLEKSNO...
ZAVISIMOST' REZUL'TATOV PANRETINAL'NOY KOAGULYATSII PRI PRE...
PRIMENENIE UBIKHINONA (KOENZIMA Q) V KOMPLEKSNOY TERAPII SA...
OSOBENNOSTI KLINIKI I DIAGNOSTIKI ISHEMICHESKOY NEFROPATII ...
GEMOSTAZ U DETEY I VZROSLYKH S SAKHARNYM DIABETOM 1 TIPA
OBSHCHEE RUKOVODSTVO MEZHDUNARODNOY DIABETICHESKOY FEDERATS...
Collapse <%$ Resources: Default, Cilt %>: 2008/11<%$ Resources: Default, Cilt %>: 2008/11
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
PROBLEMY OSTROGO INFARKTA MIOKARDA U BOL'NYKH SAKHARNYM DIA...
UROVEN' GLIKEMII I PROGNOZ OSTRYKH KORONARNYKH SINDROMOV U ...
ZNACHENIE GLIKEMICHESKOGO KONTROLYA V OSTROM PERIODE INFARK...
OPTIMIZATSIYA TERAPII BOL'NYKH IBS V SOCHETANII S ARTERIAL'...
NARUSHENIYA RITMA SERDTSA U PATSIENTOV S SAKHARNYM DIABETOM...
FUNKTSIONAL'NYE OSOBENNOSTI MIKROTSIRKULYATSII U BOL'NYKH S...
OSOBENNOSTI SUTOCHNOGO PROFILYA ARTERIAL'NOGO DAVLENIYA PRI...
KARDIOINTERVENTSIONNOE LECHENIE BOL'NYKH SAKHARNYM DIABETOM...
DIASTOLICHESKAYA DISFUNKTSIYA LEVOGO ZHELUDOCHKA U BOL'NYKH...
SAKHARNYY DIABET 2 TIPA, ARTERIAL'NAYA GIPERTENZIYA I RISK ...
BETA-ADRENOBLOKATORY PRI SERDECHNOY NEDOSTATOCHNOSTI U BOL'...
ANTIGIPERTENZIVNAYA TERAPIYA I RISK RAZVITIYA SAKHARNOGO DI...
SAKHARNYY DIABET 2 TIPA I KOGNITIVNYE NARUSHENIYA
MOZHNO LI DOSTIGNUT' EFFEKTIVNOGO GLIKEMICHESKOGO KONTROLYA...
AVANDIYA OSTAETSYA ODNIM IZ PREPARATOV VYBORA V LECHENII SA...
NOVYE SREDSTVA VVEDENIYA INSULINA KAK SPOSOB PREODOLENIYA «...
ISSLEDOVANIE ADVANCE: VLIYANIE NOLIPRELA – FIKSIROVANNOY KO...
REKOMENDATSII PO LECHENIYU SAKHARNOGO DIABETA, PREDIABETA I...
KOMMENTARII KARDIOLOGA K REKOMENDATSIYAM PO SAKHARNOMU DIAB...
KOMMENTARII ENDOKRINOLOGA K REKOMENDATSIYAM PO SAKHARNOMU D...
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
VKLAD OZHIRENIYA V PORAZHENIE POCHEK PRI SAKHARNOM DIABETE ...
SOVREMENNOE PONYATIE «KHRONICHESKAYA BOLEZN' POCHEK»: METOD...
TUBULONINTERSTITSIAL'NYY FIBROZ PRI DIABETICHESKOY NEFROPAT...
KLINICHESKIE I PATOFIZIOLOGICHESKIE OSOBENNOSTI ANEMII PRI ...
TERAPIYA ANDROGENAMI U MUZHCHIN S SAKHARNYM DIABETOM 1 TIPA...
FAKTORY RISKA RAZVITIYA I PUTI PROFILAKTIKI KONTRASTINDUTSI...
PORAZHENIYA NIZHNIKH KONECHNOSTEY U BOL'NYKH SAKHARNYM DIAB...
SRAVNENIE GEMODINAMICHESKIKH I BIOKHIMICHESKIKH EFFEKTOV KA...
OPYT PRIMENENIYA INGIBITORA ANGIOTENZINPREVRASHCHAYUSHCHEGO...
POKAZATELI GAZOOBMENA U BOL'NYKH S SAKHARNYM DIABETOM 2 TIP...
ISPOL'ZOVANIE MIKRONIZIROVANNOGO NATURAL'NOGO PROGESTERONA ...
REZUL'TATY SKRININGA SAKHARNOGO DIABETA U ZHITELEY G. ABAKA...
GLIKIROVANNYY GEMOGLOBIN KAK KLYUCHEVOY PARAMETR PRI MONITO...
APIDRA (INSULIN GLULIZIN) V TERAPII SAKHARNOGO DIABETA 1 TI...
EKONOMICHESKIE ASPEKTY SAKHARNOGO DIABETA I EGO OSLOZHNENIY
FARMAKOEKONOMICHESKIE ASPEKTY LECHENIYA SAKHARNOGO DIABETA ...
KOMMENTARII K RUKOVODSTVU RABOCHEY GRUPPY NKF-KDOQI (SSHA) ...
ISSLEDOVANIE ONTARGET: TELMISARTAN NE USTUPAET PO EFFEKTIVN...
NOVOSTI FUNDAMENTAL'NYKH ISSLEDOVANIY
NOVOSTI IV VSEROSSIYSKOGO DIABETOLOGICHESKOGO KONGRESSA
ADVANCE: INTENSIVNYY KONTROL' GLIKEMII V SNIZHENII RISKA RA...
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
DIABETICHESKAYA RETINOPATIYA: SOVREMENNYE PROBLEMY (VZGLYAD...
DIABETICHESKAYA RETINOPATIYA (VZGLYAD OFTAL'MOLOGA)
RASPROSTRANENNOST' DIABETICHESKOY RETINOPATII I KATARAKTY U...
OPTIMIZATSIYA TEKHNIKI VITREKTOMII PRI POZDNIKH STADIYAKH P...
ZNACHENIE MORFOMETRICHESKIKH PARAMETROV SETCHATKI V PROGNOZ...
KLINIKO-TOPOGRAFICHESKAYA KLASSIFIKATSIYA DIABETICHESKIKH M...
DIABETICHESKIY MAKULYARNYY OTEK: SOVREMENNYE VOZMOZHNOSTI D...
OSOBENNOSTI KHIRURGICHESKOGO LECHENIYA KATARAKTY U BOL'NYKH...
NOVYE TEKHNOLOGII VIZUALIZATSII DIABETICHESKIKH IZMENENIY S...
Collapse <%$ Resources: Default, Cilt %>: 2009/12<%$ Resources: Default, Cilt %>: 2009/12
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Efficiency of insulin analogs in young patients with type 1...
Specific features of physical development in children and a...
Assessment of quality of life as an element of monitoring h...
Insulin pump therapy of type 1 diabetes mellitus in childre...
Ketosis-prone type 2 diabetes mellitus (review of the liter...
Blood levels of stable nitric oxide metabolites in metaboli...
Danger of multiple use of insulin pen needles for diabetic ...
Can simple intensification of therapy with modern two-phase...
Feasibility of efficacious therapy of diabetes mellitus by ...
Concurrent type 1 diabetes mellitus and B-cell lymphoma in ...
On the safety of insulin Glargine
VII All-Russia Scientific and Practical Congress Healthcare...
69th Scientific Session of American Diabetes Association (A...
91st Annual Conference on endocrine system diseases (ENDO, ...
35th Annual Conference of International Society for the Stu...
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
Infertile marriage in patients with diabetes mellitus
Specific features of the establishment of puberty in girls ...
Carbohydrate metabolism in menopausal women
Male reproductive function in diabetes mellitus
The role of compensation of carbohydrate metabolism in preg...
Specific features of pregnancy in patients with type 1 diab...
Topical problems of diabetes treatment during pregnancy
Genetic markers of insulin resistance in gestational diabet...
Control of type 2 diabetes mellitus: problems and prospects...
Prevalence of renal lesions in patients with type 1 and 2 d...
Markers of inflammation in patents with type 2 diabetes and...
Diagnosis of diabetic autonomous cardioneuropathy in patien...
Factors of tubulointerstitial lesions in diabetic kidneys
Efficiency and safety of transfer of type 2 diabetes patien...
Initial glucose-lowering therapy and risks of overall and c...
In-shoe computed pedobarography as a new method for the ass...
Markers of apoptosis in patients with type 1 diabetes melli...
New strategies of insulin therapy - a way to effective glyc...
IMPROVE™ observational program: safety and effectiveness of...
The role of phenofibrate in the treatment of microvascular ...
Risk of oncological diseases in patients with diabetes mell...
Treatment of DM2 to-day. Should we change priorities? Concl...
Peculiarities of renal affection in patients with type 2 di...
Annual Congress of European Association for the Study of Di...
20th World Diabetological Congress of International Diabete...
The 9th regional conference on the treatment of type 2 diab...
World Diabetes Day
American Diabetes Association proposes to use HbA1c level f...
Collapse <%$ Resources: Default, Sayi %>: 5<%$ Resources: Default, Sayi %>: 5
Redaktorskaya stat'ya
Liraglutid - vozmozhnosti kompleksnogo terapevticheskogo po...
Klinicheskie aspekty ispol'zovaniya pervogo analoga chelove...
Issledovanie effekta i deystviya liraglutida pri sakharnom ...
Collapse <%$ Resources: Default, Cilt %>: 2010/13<%$ Resources: Default, Cilt %>: 2010/13
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
Coagulation factors II,V and methylene tetrahydrofolate red...
Metabolism of carbohydrate-containing biopolymers in liver ...
Collapse <%$ Resources: Default, Cilt %>: 1998/1<%$ Resources: Default, Cilt %>: 1998/1
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
OBRASHCHENIE MINISTRA ZDRAVOOKHRANENIYA RF
Collapse <%$ Resources: Default, Cilt %>: 1999/2<%$ Resources: Default, Cilt %>: 1999/2
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
PATOGENEZ ANGIOPATIY PRI SAKHARNOM DIABETE
Kharakteristika fazy remissii pri vpervye vyyavlennom insul...
Monitoring osnovnykh epidemiologicheskikh kharakteristik sa...
Profilaktika pozdnikh oslozhneniy sakharnogo diabeta u dete...
Osnovnye printsipy terapii sakharnogo diabeta 2 tipa
Mozhno li izbezhat' polipragmazii pri insulinzavisimom sakh...
Faktory riska bystrogo razvitiya pochechnoy nedostatochnost...
Medikamentoznaya terapiya ishemii nizhnikh konechnostey u b...
Sovremennye kontseptsii v obuchenii bol'nykh sakharnym diab...
Sakharnyy diabet i Internet
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
Polimorfizm gena endotelial'noy NO-sintazy i geneticheskaya...
Geneticheskie i immunologicheskie osobennosti sakharnogo di...
Pokazateli perekisnogo okisleniya lipidov i aktivnost' anti...
Vibratsionnaya chuvstvitel'nost' v ranney stadii diabetiche...
Primenenie Siofora (metformina) v lechenii bol'nykh sakharn...
Sovremennye podkhody k ranney diagnostike i lecheniyu spets...
Primenenie uglekislotnogo i geliy-neonovogo lazerov v leche...
Effektivnost' dipiridamola pri diabeticheskoy retinopatii u...
Primenenie piyavita pri sakharnom diabete
Opyt sovmestnogo primeneniya Andriola i Viagry v lechenii e...
Effektivnost' preparata Mil'gamma v lechenii bolevogo sindr...
Mikronizirovannyy maninil kak preparat pervogo vybora pri n...
Protektivnyy effekt T-aktivina pri eksperimental'nom sakhar...
Otchet o rabote Evropeyskogo Byuro VOZ po povysheniyu kache...
Referaty
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Prospektivnoe nablyudenie za det'mi s sakharnym diabetom 1 ...
Nozogeografiya zabolevaemosti sakharnym diabetom 1 tipa v s...
Diagnostika i klassifikatsiya sakharnogo diabeta
Arterial'naya gipertoniya i sakharnyy diabet: , mekhanizmy ...
Sostoyanie perekisnogo okisleniya lipidov v membranakh trom...
Sulodeksid v lechenii diabeticheskoy nefropatii u podrostko...
Primenenie glikozaminoglikanov v lechenii diabeticheskoy ne...
Vliyanie glyurenorma i glibenklamida na techenie diabetiche...
Napravlennyy transport antibiotikov pri lechenii bol'nykh d...
Vliyanie avtonomnogo elektrostimulyatora zheludochnokishech...
Sanatorno-reabilitatsionnoe lechenie detey s. sakharnym dia...
Sostoyanie tsitoplazmaticheskikh membran pri eksperimental'...
Lokus geneticheskoy predraspolozhennosti k diabetu I tipa
Ekonomicheskie aspekty lecheniya sakharnogo diabeta
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
Vtorichnyy diabet
Insulinsvyazyvayushchaya aktivnost' kletok krovi pri sakhar...
Oksid azota i diabeticheskie angiopatii
O znachenii interferona v patogeneze pozdnikh oslozhneniy s...
Vliyanie T-aktivina na pokazateli kletochnogo zvena immunit...
Sakharnyy diabet v pozhilom vozraste: osobennosti kliniki i...
Rezul'taty UKPDS i ikh znachenie v sovershenstvovanii spets...
Analogi insulina
Collapse <%$ Resources: Default, Cilt %>: 2011/14<%$ Resources: Default, Cilt %>: 2011/14
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Pharmalogical effects and results of clinical trials of the...
Quality of life diabetes mellitus: definitions, modern rese...
Efficacy of combined treatment of distal polyneuropathy in ...
The early combined therapy by type 2 diabetes
Glibenclamide - profile of efficacy and safety
Glibenclamide therapy: pros and cons
The results of open observational trial DIAMOND
Pharmacoeconomic analysis of conservative strategy for the ...
Pharmacoeconomic aspects of the use of sulfonylurea drugs i...
Liver transplantation on the occasion biliary cirrhosis in ...
Mauriac syndrome in adult with type 1 diabetes mellitus
The 71st Scientific Session of American Diabetes Associatio...
Queen Margrette II of Denmark has visited Endocrinology Res...
The 47th Annual meeting of the European Association for the...
Alexandr Sergeevich Ametov. On the ocassion of his 70th bir...
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
Russian Association of Endocrinologists expert consensus do...
Role of plasminogen activator inhibitor and free fatty acid...
Experience with the treatment of diabetic foot syndrome in ...
Urinary excretion of type IV collagen as an early marker of...
Simultaneous pancreas-kidney transplantation: Pro et Contra
First GLP-1 analog liraglutide: the result of clinical trai...
Effective and safe control of glycemia with insulin Apidra ...
Necrobiosis lipoidica in diabetic patients: pathogenetic an...
The efficacy of therapy with DPP-4 inhibitors combined with...
Leading causes of death and concomitant pathology in patien...
Pancreatogenic diabetes mellitus: incidence and detection r...
Peculiar features of the clinical course of reflux disease ...
Actual ambulatory care in patients with type 2 diabetes mel...
Alpha-lipoic acid in non-proliferative diabetic retinopathy...
Alpha-lipoic acid in non-proliferative diabetic retinopathy...
Biosimilars: presumption of guilt
Integrated surgical management of neuroischemic diabetic fo...
ACE inhibitors as a risk factor for hypoglycemia
On the occasion of the jubilee of Galina Afanasyevna Melnic...
On the occasion of the jubilee of Valentina Alexandrovna Pe...
Priority areas in management of diabetes mellitus type 1 & ...
21th Congress of International Diabetes Federation, 4-8 Dec...
XXV (88) Session of RAMS General Meeting, 7-9 December 2011...
Russian Association of Endocrinologists reports commencemen...
Russian Association of Endocrinologists reports commencemen...
Collapse <%$ Resources: Default, Cilt %>: 2012/15<%$ Resources: Default, Cilt %>: 2012/15
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
Modern antihyperglycemic agents prescribed in Russia for ty...
Epidemiological aspects of type 2 diabetes in the young
Polymorphic gene markers ILRA and IL2: population distincti...
Stratification of patients with type 2 diabetes mellitus fo...
Arrhythmogenic effects of hypoglycemia
The role of coagulation and inflammation in the development...
Insulin pump therapy in type 1 diabetes mellitus: education...
Collapse <%$ Resources: Default, Cilt %>: 2010/13<%$ Resources: Default, Cilt %>: 2010/13
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Efficacy and safety of medical treatment of chronic anxiety...
Experience with sitagliptin (the first DPP-4 inhibitor) app...
Efficacy and safety of metformin-sitagliptin combination fo...
Metformin and cancer mortality
Efficacious and safe control of glycemia using Apidra insul...
The level of glycemia as a risk factor of cardiovascular di...
The role of metformin in the modern strategy of treatment a...
Vildagliptin and its role in the treatment of diabetes mell...
New indications for exenatide therapy of type 2 diabetes me...
The role of human glucagon-like peptide-1 analog in therapy...
Vascular complications of type 2 diabetes mellitus beyond t...
Vildagliptin: the first innovative DDP-4 inhibitor
The use of the VersaJet hydrosurgical system in patients wi...
Factors promoting development of renal tubulointerstitial l...
Prospective study of efficacy and safety of insulin pump th...
The role of insulin analogs in the achievement of compensat...
The 125th birthday anniversary of Nikolai Adolfovich Sheres...
Ildar Ganievich Akmaev (on the occasion of his 80th birthda...
European Society Pediatric Endocrinologists Congress, 22-25...
46rd Congress of European Association for the Study of Diab...
European Medicines Agency (EMA) announces termination of Av...
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
Dynamics of main epidemiological characteristics of type 1 ...
HLA-haplotypes, anti- cell antibodies: their role in progno...
Myocardial revascularization in diabetic patients
Myocardial revascularization in diabetic patients presentin...
Cardiovascular implications of modern algorithm of hypoglyc...
Psychoneurologic characteristics of patients with type 2 di...
Quality of life in young patients with type 1 diabetes mell...
Anemia in patients with type 1 diabetes mellitus
Barriers for efficacious hypoglycemic therapy in clinical p...
International guidelines on the study of glycated hemoglobi...
Chronic wounds and diabetes mellitus: modern concept and pr...
Diabetic osteoarthropathy: modern methods of therapy
Combined or isolated transplantation of pancreas and kidney...
Excretion of amine nitrogen and ammonia in urine of pregnan...
Hypoglycemic therapy in patients on hemodialysis and perito...
The experience with the use of insulin pump therapy in chil...
Age and sex-related variations in the time of manifestation...
Changes in vegetative regulation of hemodynamics in patient...
Results of screening for depression in patients with diabet...
The influence of regional features on the formation of affe...
Socio-economic stratification of diabetic patients
The incidence of anemia syndrome in patients with type 1 di...
The role of transcutaneous oxymetry in the assessment of th...
Cerebral ischemia as a marker of depression and cognitive d...
Selected aspects of insulin pump therapy and continuous glu...
The great healer of body and soul. On the occasion of the 2...
On the accasion of the birthday of Mikhail Efimovich Zelzer
The new drug saxagliptin is now registrated in Russia
Collapse <%$ Resources: Default, Cilt %>: 2012/15<%$ Resources: Default, Cilt %>: 2012/15
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
Self-monitoring practice in patients with type 2 diabetes m...
Pre-clinical markers for diagnosis of diabetic nephropathy ...
Aggregation activity of blood formed elements in patients w...
Diabetes mellitus and pyoinflammatory diseases of ENT organ...
Humalog Mix 25 in the treatment of type 2 diabetes mellitus
Role of distal diabetic polyneuropathy in the development o...
Statins and diabetes mellitus: price of collaboration
Statin use and risk of diabetes mellitus
Commentary on prevention of cardiovascular complications in...
Modern antihyperglycemic therapy: safety and efficacy of gl...
Features of proliferative process in patients with diabetic...
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagl...
The VI All-Russian Endocrinological Congress, may 27-31, 20...
72st Scientific Session of American Diabetes Association (A...
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Associations of vascular endothelial growth factor (VEGF) g...
Association of HLA-DQ trans-heterodimers with prevalence of...
Allele variants of HLA II genes DRB1 and DQB1 regarding ris...
Functional activity and peripheral insulin resistance in pa...
Antihyperglycemic therapy in patients with type 2 diabetes ...
Ischaemic heart disease in patients with diabetes mellitus ...
Vacuum therapy for chronic wounds
Pedographic and clinical assessment of total contact cast i...
Inсretin-based therapy in patients with type 2 diabetes and...
Antidepressant therapy in complex treatment of painful diab...
Dose adjustment in insulin pump therapy: optimization of bo...
Analysis of typical approaches to outpatient management of ...
Influence of intensive glycemic control on development and ...
Metabolic and cardiovascular effects of early insulin glarg...
Pharmacoeconomic assessment of type 2 diabetes mellitus car...
Overcoming marked insulin resistance in a patient with type...
Expert committee on introduction of incretin-based therapy ...
In Memorian: Sergey Prokof'ev
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
Russian National Consensus Statement on gestational diabete...
Diabetes mellitus and other pathology in patients with INS ...
Vasculogenesis and angiogenesis in diabetes mellitus: novel...
Prospects of antigen-specific therapy in type 1 diabetes me...
Neuropsychological dynamics in patients with type 2 diabete...
Prognostic significance of proinflammatory factors in patie...
Insulin pump therapy in children with diabetes mellitus: pr...
Attitudes in patients with diabetes mellitus type 1 and typ...
Anxiety and depressive disorders in patients with diabetes ...
Glycated hemoglobin test: diagnostic difficulties in gestat...
Kidneys cytomembranes stability in pregnant women with type...
Compromised calcium and phosphorus metabolism in patients w...
Diabetes, obesity and cancer: risk and anti-risk factors
Individual stepwise intensification of insulin analogue the...
Diabetes mellitus type 2: a new indication for hypercortiso...
Targeting risk factors: a feasible way for prevention of va...
New prospects in the treatment of diabetes mellitus
Efficacy and safety of treatment with human insulin analogu...
Modern aspects of diabetes care (following 48th Annual Meet...
38th Annual Meeting of ISPAD (International Society for Ped...
Early insulin therapy Coordination Council
Series of International Russian-American educational confer...
Russian Association of Endocrinologists reports commencemen...
In memoriam: Viktor Vasil'evich Trusov
Collapse <%$ Resources: Default, Cilt %>: 2013/16<%$ Resources: Default, Cilt %>: 2013/16
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
Metformin in patients with ischemic heart disease and type ...
Heart rate variability in male patients with metabolic synd...
Glycemic disorders and coronary collateral circulation
Correlation between plasma proBNP, echocardiographic and cl...
Effects of metformin on body weight in patients with type 2...
Insulin therapy and body weight: benefits of biphasic human...
Osteoporosis and diabetes mellitus: a modern viewpoint
Cerebrovascular accidents in patients with type 2 diabetes ...
Incidence of sleep apnea in patients with various types of ...
Vascular channel reserves in patients with systemic atheros...
Modern approach to basal-bolus therapy with glargine and gl...
Type 2 diabetes mellitus: time to change the concept
Leonid Sobolev (1876–1919): At the cradle of insulin discov...
The 7th International DIP Symposium on Diabetes, Hypertensi...
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
PTPN22 polymorphisms associated with type 1 diabetes mellit...
Melatonin and diabetes: from pathophysiology to the treatme...
Circulating hepatocyte growth factor (HGF) in patients with...
Sulfonylureas and cardiovascular complications of type 2 di...
Clinical and morphological characteristics, management and ...
Conservative treatment for acute coronary syndrome in patie...
Preoperative visualization of peripheral arteries with dupl...
Heterogeneity in diabetic distal neuropathy and differentia...
Leptin secretion and severity of glycemic disorders in wome...
Semiology and clinical development of cystopathy in patient...
Alterations in hemostasis associated with pregnancy in pati...
EDGE study in Russian Federation: efficacy and safety of vi...
MODY3 in the child with type 2 diabetes mellitus phenotype:...
Vasily Shervinsky – Russian doctor, scientist, therapeutist...
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Novel technologies for the treatment and prevention of diab...
β-cell transplantation in diabetes mellitus
Type 1 diabetes mellitus in children and adolescents of Rus...
Epidemiology and ecology of type 1 diabetes mellitus in chi...
Glucagon and α-cells as a novel therapeutic target in the m...
Metformin regulates glycemic homeostasis in patients with t...
Fear of hypoglycemia and its clinical significance: a case-...
Nonverbal behavioural characteristics of children and adole...
Mechanisms of thrombogenesis associated with diabetes melli...
bFGF and TGFβ1 growth factors, inflammatory markers (IL-6, ...
Clinical and economical grounds of budgetary quotation for ...
Risk factors for diabetic autonomic cardiovascular neuropat...
Cardiorenal syndrome in patients with chronic kidney diseas...
Glucose-lowering therapies in patients with diabetes mellit...
Collapse <%$ Resources: Default, Cilt %>: 2003/6<%$ Resources: Default, Cilt %>: 2003/6
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
KLINICHESKIE, IMMUNOLOGICHESKIE I GENETICHESKIE OSOBENNOSTI...
KONTRATSEPTSIYA U ZHENSHCHIN, BOL'NYKH SAKHARNYM DIABETOM 1...
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
EPIDEMIOLOGICHESKIE ISSLEDOVANIYA SAKHARNOGO DIABETA S ISPO...
RASPROSTRANENNOST' PORAZHENIYA NIZHNIKH KONECHNOSTEY U BOL'...
OKSIDATIVNYY STRESS I TROMBOTSITARNO-KOAGULYATSIONNYY GEMOS...
SKOROST' NA/LI-PROTIVOTRANSPORTA V ERITROTSITAKH U BOL'NYKH...
VLIYANIE BIOFLAVANOIDOV NA INTENSIVNOST' SVOBODNORADIKAL'NO...
VLIYANIE GLIMEPIRIDA (AMARILA) NA SOSTOYANIE LIPIDNOGO OBME...
LANTUS (INSULIN GLARGIN): REAL'NYE PREIMUSHCHESTVA I PERSPE...
VLIYANIE GLIKVIDONA NA STRUKTURNO-FUNKTSIONAL'NOE SOSTOYANI...
NATEGLINID I GLIKLAZID — SRAVNITELNAYA EFFEKTIVNOST PREPARA...
SLUCHAY SOCHETANIYA SAKHARNOGO DIABETA I SINDROMA ELERSA-DA...
MESTNAYA ALLERGICHESKAYA REAKTSIYA NA CHELOVECHESKIY INSULI...
VLIYANIE ANTAGONISTA RETSEPTOROV ANGIOTENZINA II LOZARTANA ...
NOVOSTI OBSHCHEROSSIYSKOY OBSHCHESTVENNOY ORGANIZATSII INVA...
«MIFOLOGIYA» V DIABETOLOGII
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
KARDIAL'NAYA AVTONOMNAYA NEYROPATIYA V DIAGNOSTIKE ISHEMICH...
PROFILAKTIKA KHRONICHESKIKH OSLOZHNENIY SAKHARNOGO DIABETA ...
UL'TRAZVUKOVOE ISSLEDOVANIE POCHECHNOGO KROVOTOKA U DETEY I...
OSOBENNOSTI SEKRETSII INSULINA I DINAMIKA ANTROPOMETRICHESK...
OPYT PRIMENENIYA ANALOGA CHELOVECHESKOGO INSULINA UL'TRAKOR...
IMMOBILIZIRUYUSHCHAYA RAZGRUZOCHNAYA POVYAZKA (TOTAL CONTAC...
GLIKOGENOVAYA BOLEZN' I SAKHARNYY DIABET TIPA 1
NOVAYA VEKHA V ISPOL'ZOVANI STATINOV DLYA PROFILAKTIKI I LE...
SAKHARNYY DIABET TIPA 2 I OZHIRENIE KAK FAKTORY VYSOKOGO RI...
SOVREMENNYE PODKHODY K INSULINOTERAPII PRI SAKHARNOM DIABET...
NEFROKARDIAL'NYY SINDROM PRI SAKHARNOM DIABETE
Collapse <%$ Resources: Default, Cilt %>: 2004/7<%$ Resources: Default, Cilt %>: 2004/7
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
SRAVNENIE NEFROPROTEKTIVNYKH EFFEKTOV SELEKTIVNOGO BLOKATOR...
REZUL'TATY SKRININGA ZHITELEY KRASNOYARSKA NA SAKHARNYY DIA...
ROL' PROTEOLITICHESKIKH SISTEM V PATOGENEZE DIABETICHESKOY ...
SODERZHANIE OKSIDA AZOTA V PLAZME KROVI U BOL'NYKH SAKHARNY...
EZHEDNEVNYE DVUKRATNYE IN"EKTSII DVUKHFAZNOGO INSULINA ASPA...
SOBLYUDENIE BOL'NYMI SAKHARNYM DIABETOM REKOMENDATSIY VRACH...
DINAMIKA KLINICHESKIKH POKAZATELEY I OTSENKA KACHESTVA ZHIZ...
FARMAKOEKONOMICHESKIE ASPEKTY UMEN'SHENIYA MIKROAL'BUMINURI...
DIABETICHESKAYA KARDIOVASKULYARNAYA AVTONOMNAYA NEYROPATIYA
DIABETICHESKAYA NEFROPATIYA V USLOVIYAKH KRAYNEGO SEVERA
DISKUSSIYA PO POVODU STAT'I V. I. GAGARINA «DIABETICHESKAYA...
PROGRAMMA PO PREODOLENIYU BAR'EROV V LECHENII SAKHARNOGO DI...
KOMPLEKSNAYA DIAGNOSTIKA I DIFFERENTSIAL'NAYA DIAGNOSTIKA E...
NARUSHENIE SISTEMY GEMOSTAZA U BOL'NYKH SAKHARNYM DIABETOM
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
TRETIY VSEROSSIYSKIY DIABETOLOGICHESKIY KONGRESS
TOTAL GLUCOSE CONTROL: THE ROLE OF POST-PRANDIAL GLUCOSE
THE EARLY USE OF INSULIN IN TYPE 2 DIABETES
ISLET CELL TRANSPLANTATION
DYSLIPIDEMIAS IN DIABETES
RASPROSTRANENNOST' DIABETICHESKOY NEFROPATII U BOL'NYKH SAK...
Collapse <%$ Resources: Default, Cilt %>: 1999/2<%$ Resources: Default, Cilt %>: 1999/2
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
Sovremennye problemy insulinoterapii
Osobennosti klinicheskoy kartiny i lecheniya diabeticheskoy...
5-letniy opyt primeneniya khumaloga v pediatricheskoy prakt...
O semeynoy forme sakharnogo diabeta 2 tipa u molodykh (MODY...
Lokus geneticheskoy predraspolozhennosti k diabetu 1 tipa I...
Sindromy, assotsiirovannye s intolerantnost'yu k glyukoze i...
Collapse <%$ Resources: Default, Cilt %>: 2000/3<%$ Resources: Default, Cilt %>: 2000/3
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
Geneticheskie aspekty sakharnogo diabeta
Retinopatiya u bol'nykh sakharnym diabetom I tipa
Diabeticheskaya nefropatiya: itogi XX veka, perspektivy XXI...
Diabeticheskaya neyropatiya: epidemiologicheskie i kliniche...
Kachestvo zhizni kak vazhneyshiy pokazatel' effektivnosti l...
Poslednie dostizheniya i perspektivy profilaktiki sakharnog...
Medlenno progressiruyushchiy sakharnyy diabet 1 tipa (LADA)
Vliyanie arbidola na perekisnoe okislenie lipidov u bol'nyk...
Vliyanie preparata tanakan na svobodnoradikal'nye protsessy...
Sluchay netipichnogo techeniya DIDMOAD-sindroma
Sluchay neyropaticheskoy formy sindroma diabeticheskoy stop...
LOKUSY GENETIChESKOY PREDRASPOLOZhENNOSTI K DIABETU 1 TIPA ...
STG i IFR-1 pri sakharnom diabete: rol' v patogeneze mikros...
35-ya ezhegodnaya konferentsiya Evropeyskoy Assotsiatsii po...
Professor S.A.Abusuev (k 60-letiyu so dnya rozhdeniya)
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
Prognozirovanie SD 1 tipa v gruppakh vysokogo riska
Mutatsiya S1167T v gene katalazy i razvitie neyropatii pri ...
Problemy i perspektivy gipolipidemicheskoy terapii pri sakh...
Perspektivy lecheniya i profilaktiki sakharnogo diabeta 1 t...
Korrektsiya narushennogo kostnogo metabolizma i fosforno-ka...
Algoritm podbora effektivnoy dozy mikronizirovannogo Manini...
Vozmozhnosti korrektsii narusheniy uglevodnogo obmena pri s...
Primenenie mevakora i alisata pri metabolicheskom sindrome
Chreskozhnoe lazernoe obluchenie krovi pri diabeticheskoy r...
Primenenie biologicheski aktivnykh dobavok pri sakharnom di...
Makrososudistye oslozhneniya pri sakharnom diabete 2 tipa
Sluchay indutsirovannykh gipoglikemiy
Referaty
Il'dar Ganievich Akmaev (k 70-letiyu so dnya rozhdeniya)
«Bol'shoy spravochnik po diabetu»
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Geny antioksidantnoy zashchity i predraspolozhennost' k sak...
Okislitel'naya modifikatsiya belkov pri diabeticheskikh mik...
Erektil'naya disfunktsiya u bol'nykh sakharnym diabetom
Funktsional'naya aktivnost' trombotsitov pri sakharnom diab...
Lipidnyy obmen v sem'yakh bol'nykh sakharnym diabetom
Diabeticheskiy ketoatsidoz u detey
Fizicheskoe razvitie detey, bol'nykh sakharnym diabetom I t...
Znachenie glikirovannykh belkov pri kozhnykh oslozhneniyakh...
Collapse <%$ Resources: Default, Cilt %>: 2008/11<%$ Resources: Default, Cilt %>: 2008/11
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
SRAVNITEL'NAYA EFFEKTIVNOST' FOKAL'NOY I PANMAKULYARNOY MET...
NEFRO-RETINAL'NYY SINDROM
OTSENKA EFFEKTIVNOSTI I BEZOPASNOSTI ISPOL'ZOVANIYA INSULIN...
NOVYE VOZMOZHNOSTI V DOSTIZHENII KOMPENSATSII UGLEVODNOGO O...
VLIYANIE METFORMINA NA UGLEVODNYY I LIPIDNYY OBMEN U BOL'NY...
PROBLEMA KONTROLYA KACHESTVA DIABETOLOGICHESKOY POMOSHCHI V...
FARMAKOEKONOMICHESKIE ASPEKTY PRIMENENIYA ANALOGOV INSULINA
DIRECT. REZUL'TATY ISSLEDOVANIYA EFFEKTIVNOSTI KANDESARTANA...
HYVET. REZUL'TATY RANDOMIZIROVANNOGO DVOYNOGO SLEPOGO PLATS...
PO MATERIALAM 34-GO KONGRESSA AMERIKANSKOGO OBSHCHESTVA KAT...
NOVOSTI S KONGRESSA AMERIKANSKOY DIABETICHESKOY ASSOTSIATSI...
LIRAGLYUTID – NOVAYA STUPEN' V TERAPII SD 2 TIPA
PO MATERIALAM 32–33 KONGRESSOV MEZHDUNARODNOGO OBSHCHESTVA ...
VSEROSSIYSKAYA NAUCHNO-PRAKTICHESKAYA KONFERENTSIYA «DIABET...
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
SEKRETSIYA INSULINA PRI SAKHARNOM DIABETE 2 TIPA: OT MEZHDU...
ROL' Β-KLETOK V REGULYATSII GOMEOSTAZA GLYUKOZY V NORME I P...
METABOLICHESKAYA REGULYATSIYA I TSAMF-ZAVISIMAYA PROTEINKIN...
GETEROGENNOST' SAKHARNOGO DIABETA. AUTOIMMUNNYY LATENTNYY S...
VLIYANIE AMILINA NA FUNKTSIYU Β-KLETOK I REGULYATSIYU UGLEV...
MOLEKULYARNO-GENETICHESKIE OSOBENNOSTI, KHARAKTER METABOLIZ...
OSOBENNOSTI RAZVITIYA SAKHARNOGO DIABETA U BOL'NYKH TUBERKU...
RASPROSTRANENNOST' OSLOZHNENIY SAKHARNOGO DIABETA 2 TIPA PO...
GLIKIROVANNYY GEMOGLOBIN – OSNOVNOY PARAMETR V KONTROLE SAK...
NOVYY PODKHOD K OTSENKE KONTSENTRATSIONNOY SPOSOBNOSTI POCH...
VZAIMOSVYAZ' GENETICHESKIKH I IMMUNOLOGICHESKIKH MARKEROV U...
DETSKO-RODITEL'SKIE OTNOSHENIYA V SEM'YAKH DETEY, BOL'NYKH ...
ROL' DISLIPOPROTEINEMIY V IZMENENII LIPIDNOY FAZY MEMBRAN E...
INSULIN GLARGIN V LECHENII SAHARNOGO DIABETA 2 TIPA: DOKAZA...
NOVYE VOZMOZHNOSTI V TERAPII SD 2 TIPA: LIRAGLUTID – ANALOG...
REZUL'TATY PRIMENENIYA STRUKTURIROVANNOY PROGRAMMY OBUCHENI...
VZAIMOSVYAZ' MEZHDU AVTONOMNOY NEVROPATIEY I BESSIMPTOMNYMI...
KOMPLEKSNYY PODKHOD K OTSENKE KOMPENSATSII SAKHARNOGO DIABE...
VYBOR TAKTIKI LECHENIYA U PATSIENTOV S NEUDOVLETVORITEL'NOY...
BRITANSKOE PROSPEKTIVNOE ISSLEDOVANIE SAKHARNOGO DIABETA (U...
VOZMOZHNOSTI KLETOCHNYKH TEKHNOLOGIY V LECHENII SAKHARNOGO ...
VSEMIRNYY DEN' BOL'NOGO SAKHARNYM DIABETOM
2-Y MEZHDUNARODNYY SIMPOZIUM «DIABETICHESKAYA STOPA: KHIRUR...
ITOGI MEZHDUNARODNOGO FORUMA «OB"EDINIT'SYA DLYA BOR'BY S D...
OSKAR MINKOVSKIY – OTKRYTIE, IZMENIVSHEE MIR
ALL-RUSSIAN CONGRESS "DIABETES AND THE KIDNEY"
Collapse <%$ Resources: Default, Cilt %>: 2009/12<%$ Resources: Default, Cilt %>: 2009/12
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
PRINCIPLES OF CARE IN DIABETIC FOOT PATIENTS IN RUSSIA
POSSIBILITIES OF COMBINED SURGICAL TREATMENT OF PYONECROTIC...
UP-TO-DATE PRINCIPLES OF DIAGNOSTICS AND TREATMENT OF CHRON...
USE OF BIATAIN DRESSING MATERIAL IN PATIENTS WITH DIABETIC ...
MEDICAL CARE IN DIABETIC FOOT PATIENTS IN ST. PETERSBURG
THE SYSTEM OF OSTEOPROTEGRIN (OPG)/LIGAND OF NF-KB RECEPTOR...
ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADOLESCENTS WITH TY...
IMPLEMENTATION OF DIABETES MELLITUS PROGRAM IN THE TYUMEN R...
Collapse <%$ Resources: Default, Cilt %>: 2000/3<%$ Resources: Default, Cilt %>: 2000/3
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Sochetanie sakharnogo diabeta u detey s drugimi endokrinnym...
O lechenii diabeticheskoy retinopatii
Ekonomicheskie problemy sakharnogo diabeta v Rossii
Sostoyanie endoteliya i adgeziya leykotsitov pri sakharnom ...
Дедов И.И., Шестакова М.В. «Диабетическая нефропатия» Москв...
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
I.I. Dedov (K 60 - letiyu so dnya rozhdeniya)
Geneticheskie narusheniya pri sakharnom diabete vzroslogo t...
Kislotnaya zheludochnaya sekretsiya u bol'nykh sakharnym di...
Belki sleznoy zhidkosti v diagnostike i prognoze diabetiche...
Vliyanie tsilazaprila na produktsiyu aktivnykh form kisloro...
Autoantitela k insulinu, sakharnyy diabet I tipa i diabetic...
Skrining diabeticheskoy retinopatii (Opyt kliniki endokrino...
Rezul'taty primeneniya tioktatsida v lechenii diabetichesko...
Primenenie allikora pri sakharnom diabete 2 tipa
O lechenii sakharnogo diabeta 2 tipa glimepiridom
O kontrole glikemii u detey i podrostkov s sakharnym diabet...
Sakharnyy diabet pri ataksii Fridreykha
Perechen' dissertatsiy po spetsial'nosti «Endokrinologiya»
Collapse <%$ Resources: Default, Cilt %>: 2001/4<%$ Resources: Default, Cilt %>: 2001/4
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
Nekotorye aspekty patogeneza sakharnogo diabeta u detey, pe...
Perekisnoe okislenie lipidov, antioksidantnaya zashchita i ...
EPR spektroskopiya pri ozhirenii i metabolicheskom sindrome...
Differentsirovannaya chuvstvitel'nost' r kletochnykh i ekst...
Neyroendokrinnye narusheniya i sostoyanie tsentral'noy nerv...
Primenenie nikotinamida i drugikh antioksidantnykh preparat...
Primenenie preparata Namivit v terapii sakharnogo diabeta
Insulinorezistentnost' v patogeneze sakharnogo diabeta 2 ti...
Nebivolol i dislipidemiya u bol'nykh sakharnym diabetom 2 t...
Effektivnost' i mesto siofora (metformina) v terapii sakhar...
Antioksidanty v lechenii i profilaktike sakharnogo diabeta
Morfogenez mikroangiopatiy pri sakharnom diabete
Poisk informatsii o diabete v Internete
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
SINDROM DIABETICHESKOY STOPY
DIABETICHESKAYA MAKROANGIOPATIYA NIZHNIKH KONECHNOSTEY: KLI...
DIABETICHESKAYA MIKROANGIOPATIYA V GENEZE SINDROMA DIABETIC...
KLINIKO-MORFOLOGICHESKIE KHARAKTERISTIKI REPARATSII TKANEY ...
PRINTSIPY MESTNOGO LECHENIYA TROFICHESKIKH YAZV STOP U BOL'...
SOVREMENNYE IMMOBILIZATSIONNYE MATERIALY V LECHENII SINDROM...
VOZMOZHNOSTI ISPOL'ZOVANIYA NEYROMUL'TIVITA V KOMPLEKSNOY T...
MAKROSOSUDISTAYA REAKTIVNOST' U BOL'NYKH SAKHARNYM DIABETOM...
ROL' STATINOV V KORREKTSII DIABETICHESKOY DISLIPIDEMII
ROL' NA+ - N+ OBMENNIKA V PATOGENEZE SAKHARNOGO DIABETA 2 T...
SMERTNOST' SREDI BOL'NYKH SAKHARNYM DIABETOM PO DANNYM TERR...
PROGRESSIROVANIE DIABETICHESKOY RETINOPATII PRI BYSTROY KOM...
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
DIABETICHESKAYA NEFROPATIYA: SOSTOYANIE PROBLEMY V MIRE I V...
EKSKRETSIYA FOSFOLIPIDOV S MOCHOY U BOL'NYKH DIABETICHESKOY...
Collapse <%$ Resources: Default, Cilt %>: 2004/7<%$ Resources: Default, Cilt %>: 2004/7
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
VZAIMODEYSTVIE PSIKHOEMOTSIONAL'NOGO STATUSA I STEPENI DEKO...
SOVREMENNYE ASPEKTY TRANSPLANTATSII OSTROVKOV PODZHELUDOCHN...
GIPERTROFIYA LEVOGO ZHELUDOCHKA U BOL'NYKH SAKHARNYM DIABET...
SAKHARNYY DIABET I ENDOTELIAL'NAYA DISFUNKTSIYA
PSIKHOEMOTSIONAL'NYE RASSTROYSTVA PRI NEKOTORYKH ENDOKRINNY...
DIDMOAD SINDROM. KLINICHESKIY RAZBOR
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
EPIDEMIOLOGICHESKAYA KHARAKTERISTIKA SAKHARNOGO DIABETA 1 T...
EPIDEMIOLOGICHESKAYA KHARAKTERISTIKA SAKHARNOGO DIABETA 1 T...
SOSTOYANIE TROMBOTSITARNOGO GEMOSTAZA U DETEY S SAKHARNYM D...
OZHIRENIE I VROZHDENNYY GIPOPITUITARIZM
ROL' SVOBODNORADIKAL'NO OPOSREDOVANNOGO OKISLITEL'NOGO STRE...
EREKTIL'NAYA DISFUNKTSIYA U BOL'NYKH S MALOY DLITEL'NOST'YU...
CHASTOTA DIABETICHESKOY KARDIAL'NOY AVTONOMNOY NEYROPATII U...
ROL' I MESTO ENDOGENNYKH PROTEKTORNYKH SISTEM OKSID AZOTA-B...
VLIYANIE SELMEVITA NA MEMBRANY I KOAGULYATSIONNUYU AKTIVNOS...
INDIVIDUAL'NYE KHARAKTERISTIKI BOL'NYKH SAKHARNYM DIABETOM ...
ISSLEDOVANIE EFFEKTIVNOSTI I BEZOPASNOSTI PRIMENENIYA PERVO...
IMMUNOLOGICHESKIE MARKERY V DIAGNOSTIKE I PROGNOZIROVANII S...
AKARBOZA SNIZHAET RISK RAZVITIYA INFARKTA MIOKARDA U PATSIE...
NEKROLOG. VLADIMIR YAKOVLEVICH IGNATKOV
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
DINAMIKA KLYUCHEVYKH MEDIATOROV INSULINOREZISTENTNOSTI U BO...
KARDIO- I NEFROPROTEKTIVNYE EFFEKTY AGONISTA IMIDAZOLINOVYK...
PREDIKTORY VYZHIVAEMOSTI BOL'NYKH KHRONICHESKOY SERDECHNOY ...
OTSENKA SUBFRAKTSIONNOGO SOSTAVA MOCHI U BOL'NYKH SAKHARNYM...
FARMAKOEKONOMICHESKIY ANALIZ ISPOL'ZOVANIYA INTENSIVNOY TAK...
AUTOIMMUNNYY POLIGLANDULYARNYY SINDROM III TIPA (DTZ, SAKHA...
SOCHETANIE SAKHARNOGO DIABETA I SINDROMA MNOZHESTVENNOY EKZ...
SISTEMA ANGIOGENEZA V NORME I PRI SAKHARNOM DIABETE
REZUL'TATY ISSLEDOVANIYA INSIGHT V GRUPPE PATSIENTOV S SAKH...
VLIYANIE OZHIRENIYA NA TOLSHCHINU KOMPLEKSA INTIMA — MEDIA ...
SOVREMENNYE REKOMENDATSII PO ISPOL'ZOVANIYU ZAMESTITEL'NOY ...
VLIYANIE VNUTRIMATOCHNYKH KONTRATSEPTIVNYKH SREDSTV NA POKA...
REFERATY ZARUBEZHNYKH ISSLEDOVATELEY
K SVEDENIYU AVTOROV
Collapse <%$ Resources: Default, Cilt %>: 2005/8<%$ Resources: Default, Cilt %>: 2005/8
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
POLIMORFIZM GENA GLAVNOGO KOMPLEKSA GISTOSOVMESTIMOSTI KLAS...
SRAVNENIE ANTAGONISTOV ANGIOTENZINOVYKH RETSEPTOROV S INGIB...
SOSTOYANIE MIKROTSIRKULYATSII U PATSIENTOV NA RAZNYKH STADI...
OSOBENNOSTI MIKROREOLOGICHESKIKH SVOYSTV ERITROTSITOV PRI S...
OSOBENNOSTI DIABETICHESKOY RETINOPATII V DETSKOM VOZRASTE
ATEROSKLEROZ I FAKTORY ROSTA (TGFBL I BFGF) U PATSIENTOV S ...
EREKTIL'NAYA DISFUNKTSIYA KAK ODNO IZ PROYAVLENIY DEKOMPENS...
OBMEN GLIKOZAMINOGLIKANOV U BOL'NYKH SAKHARNYM DIABETOM DIA...
OSOBENNOSTI BIOMEKHANIKI STOPY PRI DIABETICHESKOY ARTROPATI...
SOVREMENNAYA KONTSEPTSIYA VEDENIYA BOL'NYKH S KHRONICHESKIM...
EFFEKTIVNOST' I BEZOPASNOST' PIOGLITAZONA (AKTOS™) V KACHES...
REFERATY ZARUBEZHNYKH PUBLIKATSIY
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
GOSUDARSTVENNYY REGISTR BOL'NYKH SAKHARNYM DIABETOM — OSNOV...
RASPROSTRANENNOST' SAKHARNOGO DIABETA 2 TIPA (PO DANNYM SKR...
REZUL'TATY SKRININGA OSLOZHNENIY SAKHARNOGO DIABETA V TYUME...
GENETICHESKIE MARKERY I IKH VZAIMOSVYAZ' S OBMENOM LIPIDOV ...
OTRITSATEL'NOE VLIYANIE DINAMICHESKOY FIZICHESKOY NAGRUZKI ...
PREDIKTORY ANGIOPATIY U PATSIENTOV S NARUSHENNOY TOLERANTNO...
IMMUNODIAGNOSTIKA DOKLINICHESKIKH FORM SAKHARNOGO DIABETA 1...
OTSENKA KLINICHESKOGO PRIMENENIYA LANTUSA (INSULINA GLARGIN...
VOZMOZHNOSTI I PROBLEMY TRANSPLANTATSII Β-KLETOK PODZHELUDO...
IMMUNOVOSPALITEL'NYE MARKERY ATEROSKLEROZA U PATSIENTOV S N...
VLIYANIE VNUTRIMATOCHNYKH I KOMBINIROVANNYKH ORAL'NYKH KONT...
ROL' SINTETICHESKOGO LIGANDA PPARY-ROSIGLITAZONA V PATOGENE...
PPARΓ — PREDSTAVITEL' SEMEYSTVA YADERNYKH STEROIDNYKH RETSE...
REFERATY ZARUBEZHNYKH PUBLIKATSIY
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
SOSTOYANIE I RAZVITIE DIABETOLOGICHESKOY SLUZHBY V ROSSIYSK...
NEYROIMMUNOENDOKRINNYE ASPEKTY PATOGENEZA SAKHARNOGO DIABET...
GENETIKA SAKHARNOGO DIABETA: ISTORIYA I SOVREMENNOE SOSTOYA...
DIABETICHESKAYA RETINOPATIYA
DIABETICHESKAYA NEFROPATIYA: DOSTIZHENIYA V DIAGNOSTIKE, PR...
SOVREMENNYE PRINTSIPY VEDENIYA BOL'NYKH S SINDROMOM DIABETI...
SAKHARNYY DIABET I ISHEMICHESKAYA BOLEZN' SERDTSA: POISKI R...
EPIDEMIOLOGIYA I GOSUDARSTVENNYY REGISTR SAKHARNOGO DIABETA
OZHIRENIE I SAKHARNYY DIABET: OBSHCHNOST' ETIOLOGII I PROFI...
TERAPEVTICHESKOE OBUCHENIE V ROSSII: REZUL'TATY 15-LETNEGO ...
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
KININ-KALLIKREINOVAYA SISTEMA PRI MAKROSOSUDISTYKH OSLOZHNE...
METABOLIZM KOLLAGENA I KOLLAGENOLITICHESKAYA AKTIVNOST' SYV...
VLIYANIE HBV- I HCV- INFEKTSII NA RAZVITE AUTOIMMUNNOGO OTV...
OSOBENNOSTI SAKHARNOGO DIABETA V POZHILOM VOZRASTE I PRINTS...
POKAZATELI LIPIDNOGO SPEKTRA U BOL'NYKH SAKHARNYM DIABETOM ...
SOVREMENNYE ASPEKTY MESTNOGO LECHENIYA KHRONICHESKIKH RAN N...
VLIYANIE ASPIRINA NA TROMBOTSITARNOE ZVENO GEMOSTAZA U PATS...
IZMENENIE MOZGOVOGO KROVOTOKA U DETEY I PODROSTKOV S SAKHAR...
KARDIOVASKULYARNYE NARUSHENIYA U DETEY PRI SAKHARNOM DIABET...
KOMENTARII K STAT'E «KARDIOVASKULYARNYE NARUSHENIYA U DETEY...
KLINIKO-DIAGNOSTICHESKOE ZNACHENIE ISSLEDOVANIYA FUNKTSII V...
DINAMIKA ZABOLEVAEMOSTI SAKHARNYM DIABETOM 1 TIPA I EE PROG...
SOSTOYANIE I PERSPEKTIVY DIABETOLOGICHESKOY SLUZHBY V TYUME...
ZARUBEZHNYE NOVOSTI
Collapse <%$ Resources: Default, Cilt %>: 2006/9<%$ Resources: Default, Cilt %>: 2006/9
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
POLIMORFIZM GENOV HLA KLASSA II I CTLA4 ZDOROVYKH BURYAT I ...
MOLEKULYARNYE NARUSHENIYA MEMBRANY ERITROTSITOV PRI SOSUDIS...
INSULINRETSEPTORNOE VZAIMODEYSTVIE V LIMFOTSITAKH I ERITROT...
ANALOGI INSULINA (INSULIN DETEMIR I INSULIN ASPART) V SRAVN...
PRIMENENIE PREDUKTALA PRI LECHENII BOL'NYKH ARTERIAL'NOY GI...
TSEREBROVASKULYARNYE ZABOLEVANIYA I SAKHARNYY DIABET 2 TIPA
METABOLICHESKIE PREDPOSYLKI RAZVITIYA NARUSHENIY RITMA SERD...
KOMMENTARII K STAT'E «METABOLICHESKIE PREDPOSYLKI RAZVITIYA...
ALGORITMY VYBORA PEREVYAZOCHNOGO MATERIALA DLYA LECHENIYA S...
PRICHINY NEEFFEKTIVNOSTI INGIBITOROV FOSFODIESTERAZY-5 U BO...
PREDIKTORY RAZVITIYA OSTEOPENII PRI SAKHARNOM DIABETE TIPA ...
OPYT PRIMENENIYA LANTUSA (GLARGIN) U DETEY I PODROSTKOV S S...
OTECHESTVENNYY OPYT PRIMENENIYA ANALOGA INSULINA KOROTKOGO ...
ZARUBEZHNYE NOVOSTI (PEREVOD SEVERINOY A.S.)
Collapse <%$ Resources: Default, Sayi %>: 2<%$ Resources: Default, Sayi %>: 2
RISK RAZVITIYA SAKHARNOGO DIABETA 1 TIPA V POPULYATSII BASH...
EPIDEMIOLOGIYA SAKHARNOGO DIABETA 1 TIPA U DETEY I PODROSTK...
OKISLITEL'NYY STRESS U BOL'NYKH SAKHARN'M DIABETOM TIPA 2 S...
SOSTOYANIE PRO- I ANTIKOAGULYANTNYKH SISTEM PRI «PREDIABETE...
ISPOL'ZOVANIE INKRETINOV V LECHENII SAKHARNOGO DIABETA 2 TI...
COMBINED THERAPY WITH INSULIN LISPRO MIX 75/25 PLUS METFORM...
DVUKHFAZNYY INSULIN ASPART 30 PLYUS METFORMIN: EFFEKTIVNAYA...
GORMONAL'NAYA RILIZING-SISTEMA «NOVA-RING» U ZHENSHCHIN S S...
STRUKTURNO-METABOLICHESKIY STATUS I FUNKTSIONAL'NAYA AKTIVN...
EKONOMICHESKIY EFFEKT ISPOL'ZOVANIYA SOVREMENNYKH TEKHNOLOG...
SOVREMENNYE ASPEKTY PATOGENEZA PARODONTITA U BOL'NYKH SAKHA...
OTSENKA EFFEKTIVNOSTI TROKSEVAZINA U BOL'NYKH S PROLIFERATI...
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
KLINICHESKIE, GENETICHESKIE I METABOLICHESKIE OSOBENNOSTI S...
VOZMOZHNYE MEKHANIZMY ANTIATEROSKLEROTICHESKOGO EFFEKTA GLY...
EFFEKTIVNOST' I BEZOPASNOST' KOMBINIROVANNOY TERAPII ROSIGL...
NOVYE VOZMOZHNOSTI V KORREKTSII DISFUNKTSII ENDOTELIYA U BO...
PRIMENENIE PODSLASTITELEY V DIETOTERAPII SAKHARNOGO DIABETA
SOVREMENNOE SOSTOYANIE I PERSPEKTIVY RAZVITIYA OFTAL'MOKHIR...
LECHENIE KATARAKTY U DETEY S SAKHARNYM DIABETOM 1 TIPA
FAKTORY RISKA DIABETICHESKOY RETINOPATII
IZUCHENIE EFFEKTIVNOSTI AL'FA-LIPOEVOY KISLOTY U PATSIENTOV...
SOCHETANNAYA PATOLOGIYA: SAKHARNYY DIABET I TUBERKULEZ, OTS...
REKOMENDATSII PO IZGOTOVLENIYU ORTOPEDICHESKOY OBUVI DLYA P...
SOVREMENNYE ASPEKTY PATOGENEZA SAKHARNOGO DIABETA 1 TIPA
MOZGOVOY NEYROTROFICHESKIY FAKTOR: PATOGENETICHESKAYA SVYAZ...
Collapse <%$ Resources: Default, Sayi %>: 4<%$ Resources: Default, Sayi %>: 4
EDITORIAL NOTE
SODERZHANIE NEKOTORYKH PRO- I PROTIVOVOSPALITEL'NYKH TSITOK...
TREKHLETNIY OPYT ISPOL'ZOVANIYA INSULINOV'K POMP V KLINICHE...
OPTIMIZATSIYA FARMAKOTERAPII U BOL'NYKH SAKHARNYM DIABETOM ...
FIZIOLOGICHESKAYA ROL' INKRETINOV: PERSPEKTIVY LECHENIYA BO...
ROL' BAZAL'NOGO INSULINA V LECHENII SAKHARNOGO DIABETA 2 TI...
FAKTORY SOSUDISTOGO RISKA, KOGNITIVNYE RASSTROYSTVA I IZMEN...
DIABETICHESKAYA NEFROPATIYA: VSE LI FAKTORY RISKA MY UCHITY...
STRUKTURA POZDNIKH SOSUDISTYKH OSLOZHNENIY PRI VPERVYE VYYA...
SKRINING OSLOZHNENIY SAKHARNOGO DIABETA KAK METOD OTSENKI L...
OSNOVNYE PRINTSIPY LECHENIYA DIABETICHESKOY NEYROOSTEOARTRO...
APOPTOZ V RAZVITII REMISSII SAKHARNOGO DIABETA 1 TIPA
REZUL'TATY SKRININGA SAKHARNOGO DIABETA 2 TIPA I DRUGIKH NA...
REZOLYUTSIYA V VSEROSSIYSKOGO KONGRESSA ENDOKRINOLOGOV
SOSTAV ISPOLKOMA ROSSIYSKOY ASSOTSIATSII ENDOKRINOLOGOV
PRAVLENIE ROSSIYSKOY ASSOTSIATSII ENDOKRINOLOGOV
SEKTSII ROSSIYSKOY ASSOTSIATSII ENDOKRINOLOGOV I IKH RUKOVO...
Collapse <%$ Resources: Default, Cilt %>: 2007/10<%$ Resources: Default, Cilt %>: 2007/10
Collapse <%$ Resources: Default, Sayi %>: 1<%$ Resources: Default, Sayi %>: 1
REZOLYUTSIYA OON PO SAKHARNOMU DIABETU
VLIYANIE KOMPENSATSII UGLEVODNOGO OBMENA I TERAPII ATORVAST...
SOVREMENNYE VOZMOZHNOSTI FARMAKOTERAPII SAKHARNOGO DIABETA ...
NOVYE VOZMOZHNOSTI INSULINOTERAPII SAKHARNOGO DIABETA U DET...
OTSENKA STEPENI KOMPENSATSII UGLEVODNOGO OBMENA DIABETICHES...
OPYT PRIMENENIYA DIBIKORA PRI SAKHARNOM DIABETE 2 TIPA
Collapse <%$ Resources: Default, Cilt %>: 2009/12<%$ Resources: Default, Cilt %>: 2009/12
Collapse <%$ Resources: Default, Sayi %>: 3<%$ Resources: Default, Sayi %>: 3
Prospects for therapy aimed at restoring the beta-cell pool...
Clinical and genetic heterogeneity of neonatal diabetes mel...
Clinical features and differential diagnosis of type 2 diab...
Dynamics of incidence and prevalence of type 1 diabetes mel...
Association of type 1 diabetes mellitus (DM1) with polymorp...